Stock Analysts

Sanofi (SNY) Finalizes Deal for European Generic Unit Sale

Sanofi SNY announced that it has finalized its negotiations with private equity firm, Advent International to sell Zentiva, Sanofi’s generic business unit in Europe. The companies have signed a share purchase agreement worth $2.2 billion (1.9 billion euros). With the signing of this share purchase agreement, the closure of the transaction is now subject to approval from relevant regulatory authorities. […]

Stock Analysts

Raytheon Wins $93M Air Force Deal for Small Diameter Bomb II

Raytheon Company ’s RTN Missile Systems (MS) business unit recently won a $93 million modification contract for the integration of Small Diameter Bomb II (SDB II) in F/A-18E/F aircraft. The contract was awarded by the Air Force Life Cycle Management Center, Eglin Air Force Base, Florida. Details of the Deal Per the terms of the deal, Raytheon will provide testing, analysis and support services along with the sustainment of SDB II weapon onto the F/A-18E/F platform with additional developmental and operational testing […]

Stock Analysts

KB Home (KBH) Q2 Earnings & Revenues Beat on Strong Demand

KB Home ’s KBH shares have gained more than 4% in the after-hour trading session yesterday, after it reported stellar second-quarter fiscal 2018 results. Not only the homebuilder’s top and bottom lines surpassed the Zacks Consensus Estimate but also considerably increased year over year, courtesy of solid housing market. This Zacks Rank #3 (Hold) company’s shares have gained 6.7% in the past year, outperforming its industry ’s growth of 1.4%. […]

Stock Analysts

Pfizer’s Leukemia Candidate Gets Priority Review From FDA

Pfizer, Inc PFE announced that the FDA has granted a priority review to its new drug application (NDA) filed for the pipeline candidate glasdegib. Pfizer is looking to get glasdegib approved for the first-line treatment of acute myeloid leukemia (AML) in combination with a chemotherapy treatment with respect to patients, ineligible for intensive chemotherapy. […]

Mergers & Acquisitions

Steel Dynamics Completes Acquisition of CSN Heartland Flat Roll Operations

Steel Dynamics Completes Acquisition of CSN Heartland Flat Roll Operations PR Newswire FORT WAYNE, Ind., June 29, 2018 FORT WAYNE, Ind. , June 29, 2018 /PRNewswire/ — Steel Dynamics, Inc. (NASDAQ/GS: STLD) today announced the completion of the acquisition of Heartland Steel Processing, LLC (formerly known as Companhia Siderurgica Nacional, LLC) (“Heartland”) […]

Stock Analysts

Lilly’s (LLY) Taltz Positive in Ankylosing Spondylitis Study

Pharma giant Eli Lilly and Company LLY announced positive top-line results from a second phase III study on its arthritis drug, Taltz (ixekizumab), for the treatment of Ankylosing Spondylitis (AS), also known as radiographic axial spondyloarthritis (r-axSpA). The phase III study, COAST-W, evaluated the safety and efficacy of Taltz for the treatment of AS. This is the first AS trial on a patient population with inadequate response to one or two tumor necrosis factor (TNF) inhibitors or intolerance to a TNF inhibitor. […]

Stock Analysts

AmEx to Up Dividend, Share Buyback Post Stress Test Clearance

American Express Co. AXP announced that it will increase the quarterly dividend by 11.4% to 39 cents per share, beginning the third quarter. It also plans to repurchase up to $3.4 billion of common shares during the CCAR (Comprehensive Capital Analysis and Review) approval period of the third quarter of 2018 through the second quarter of 2019 […]